Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Norden Gregory, Director. Officer active across 4 companies, notably NanoString Technologies Inc. Cumulatively, 29 reports have been logged. Breakdown: 1 buy · 4 sells. Total volume traded: €2.1m. History available since 25 June 2021. The latest transaction was disclosed on 14 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Gregory Norden is a Board Member at NanoString Technologies Inc, Royalty Pharma plc, and Praxis Precision Medicines, Inc. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the biopharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.